LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced today that management has begun preliminary due diligence and strategic planning for the company’s planned expansion into Colombia. The initial phase includes evaluating corporate, regulatory, legal, operational, and commercial requirements for establishing a Colombian operating subsidiary.
The company believes Colombia represents an attractive long-term market as it continues its broader Latin American expansion strategy. The ongoing review will assess corporate formation, regulatory compliance, healthcare technology implementation, strategic partnerships, and local operational infrastructure. The evaluation aims to build upon LataMed’s growing healthcare ecosystem by identifying opportunities to expand access to telehealth, care coordination, digital healthcare services, insurance accessibility, pharmacy integration, payment solutions, and AI-driven healthcare technologies.
Management sees significant opportunities in improving healthcare accessibility across underserved Latin American markets through digital infrastructure. Dr. Kevin Rodan Levy, CEO, stated: “Colombia represents an important strategic opportunity as we continue executing our long-term vision of building an integrated digital healthcare ecosystem across Latin America. We are encouraged by the opportunities we see in Colombia and look forward to providing updates as the evaluation process progresses.”
The company emphasized the initiative remains in preliminary planning stages, with management intending to complete required reviews before proceeding. Further updates will be provided as material developments occur. For additional information, visit https://latamed.ai or review the company’s filings with the SEC at www.sec.gov.
LataMed AI Corp. focuses on building telehealth infrastructure, healthcare coordination tools, analytics, and AI-enabled solutions for emerging markets, with an initial regional focus on Latin America.
